Bicara Therapeutics Inc.

BCAX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
144 Mar 25, 2026
4 Mar 24, 2026 FORM 4
144 Mar 23, 2026
4 Mar 20, 2026 FORM 4
144 Mar 20, 2026
144 Mar 19, 2026
144 Mar 18, 2026
4 Mar 17, 2026 FORM 4
144 Mar 16, 2026
4 Mar 11, 2026 FORM 4
144 Mar 9, 2026
4 Mar 6, 2026 FORM 4
144 Mar 6, 2026
4 Mar 5, 2026 FORM 4
4 Mar 5, 2026 FORM 4
4 Mar 5, 2026 FORM 4
144 Mar 5, 2026
144 Mar 4, 2026
144 Mar 4, 2026
144 Mar 4, 2026
144 Mar 3, 2026
144 Mar 3, 2026
144 Mar 3, 2026
SCHEDULE 13D/A Mar 2, 2026
4 Mar 2, 2026
← Newer Page 4 of 11 · 263 filings Older →